Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/130988
Title: | Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study |
Author: | Bisbal, Felipe Alarcón, Francisco Ferrero, Ángel González Ferrer, Juan José Alonso, Concepción Pachón, Marta Tizón, Helena Cabanas Grandío, Pilar Sánchez, Manuel Benito, Eva Teis, Albert Ruiz Granell, Ricardo Pérez Villacastín, Julián Viñolas, Xavier Arias, Miguel Ángel Vallés, Ermengol García Campo, Enrique Fernández Lozano, Ignacio Villuendas, Roger Mont Girbau, Lluís |
Keywords: | Fibril·lació auricular Arrítmia Cirurgia cardíaca Assaigs clínics Atrial fibrillation Arrhythmia Heart surgery Clinical trials |
Issue Date: | 1-Sep-2018 |
Publisher: | Oxford University Press |
Abstract: | Aims: Left atrial (LA) remodelling is a key determinant of atrial fibrillation (AF) ablation outcome. Optimal methods to assess this process are scarce. LA sphericity is a shape-based parameter shown to be independently associated to procedural success. In a multicentre study, we aimed to test the feasibility of assessing LA sphericity and evaluate its capability to predict procedural outcomes. Methods and results: This study included consecutive patients undergoing first AF ablation during 2013. A 3D model of the LA chamber, excluding pulmonary veins and LA appendage, was used to quantify LA volume (LAV) and LA sphericity (≥82.1% was considered spherical LA). In total, 243 patients were included across 9 centres (71% men, aged 56 ± 10 years, 44% with hypertension and 76% CHA2DS2-VASc ≤ 1). Most patients had paroxysmal AF (66%) and underwent radiofrequency ablation (60%). Mean LA diameter (LAD), LAV, and LA sphericity were 42 ± 6 mm, 100 ± 33 mL, and 82.6 ± 3.5%, respectively. Adjusted Cox models identified paroxysmal AF [hazard ratio (HR 0.54, P = 0.032)] and LA sphericity (HR 1.87, P = 0.035) as independent predictors for AF recurrence. A combined clinical-imaging score [Left Atrial Geometry and Outcome (LAGO)] including five items (AF phenotype, structural heart disease, CHA2DS2-VASc ≤ 1, LAD, and LA sphericity) classified patients at low (≤2 points) and high risk (≥3 points) of procedural failure (35% vs. 82% recurrence at 3-year follow-up, respectively; HR 3.10, P < 0.001). Conclusion: In this multicentre, real-life cohort, LA sphericity and AF phenotype were the strongest predictors of AF ablation outcome after adjustment for covariates. The LAGO score was easy to implement, identified high risk of procedural failure, and could help select optimal candidates. Clinical Trial Registration Information: NCT02373982 (http://clinicaltrials.gov/ct2/show/NCT02373982). |
Note: | Versió postprint del document publicat a: https://doi.org/10.1093/ehjci/jey060 |
It is part of: | European Heart Journal-Cardiovascular Imaging, 2018, vol. 19, num. 9, p. 1002-1009 |
URI: | http://hdl.handle.net/2445/130988 |
Related resource: | https://doi.org/10.1093/ehjci/jey060 |
ISSN: | 2047-2404 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
685951.pdf | 514.33 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.